|
Mast Cells and Its Proteases in COPD
RECRUITINGN/ASponsored by Voronezh N.N. Burdenko State Medical Academy
Actively Recruiting
PhaseN/A
SponsorVoronezh N.N. Burdenko State Medical Academy
Started2019-01-29
Est. completion2025-08-30
Eligibility
Age20 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06392334
Summary
Mast cells proteases such as chymase and tryptase will be studied in the tissue of small and large airways in COPD patients
Eligibility
Age: 20 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria: \- COPD patients Exclusion Criteria: Other lung diseases, tumors, pregnancy \-
Conditions2
COPDCOPD Exacerbation
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorVoronezh N.N. Burdenko State Medical Academy
Started2019-01-29
Est. completion2025-08-30
Eligibility
Age20 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06392334